Oxbow Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$260K Hold
955
– – 0.02% 226
2026
Q2
$237K Buy
+955
New +$206K 0.02% 245
2024
Q4
– Sell
-1,735
Closed -$298K – 220
2024
Q3
$298K Hold
1,735
– – 0.03% 169
2024
Q2
$267K Sell
1,735
-1,368
-44% -$205K 0.03% 186
2024
Q1
$477K Sell
3,103
-1,821
-37% -$278K 0.07% 127
2023
Q4
$778K Sell
4,924
-85
-2% -$12.2K 0.12% 101
2023
Q3
$733K Sell
5,009
-6,601
-57% -$1.01M 0.12% 95
2023
Q2
$1.78M Buy
11,610
+370
+3% +$57.7K 0.28% 55
2023
Q1
$1.74M Sell
11,240
-1,025
-8% -$161K 0.31% 55
2022
Q4
$1.89M Buy
12,265
+488
+4% +$72K 0.36% 50
2022
Q3
$1.55M Buy
11,777
+267
+2% +$37.5K 0.24% 68
2022
Q2
$1.56M Sell
11,510
-185
-2% -$25.5K 0.22% 74
2022
Q1
$1.74M Hold
11,695
– – 0.18% 82
2021
Q4
$1.89M Buy
11,695
+220
+2% +$35.6K 0.18% 85
2021
Q3
$1.91M Buy
11,475
+1,040
+10% +$178K 0.19% 93
2021
Q2
$1.8M Buy
10,435
+190
+2% +$31.4K 0.19% 99
2021
Q1
$1.64M Hold
10,245
– – 0.2% 94
2020
Q4
$1.72M Hold
10,245
– – 0.22% 86
2020
Q3
$1.61M Hold
10,245
– – 0.2% 92
2020
Q2
$1.72M Sell
10,245
-425
-4% -$66.7K 0.25% 88
2020
Q1
$1.4M Sell
10,670
-475
-4% -$67.7K 0.24% 95
2019
Q4
$1.66M Hold
11,145
– – 0.19% 110
2019
Q3
$1.38M Sell
11,145
-625
-5% -$83.2K 0.18% 119
2019
Q2
$1.66M Buy
11,770
+2,200
+23% +$304K 0.2% 111
2019
Q1
$1.44M Sell
9,570
-190
-2% -$27.3K 0.18% 117
2018
Q4
$1.21M Sell
9,760
-15,490
-61% -$2.12M 0.16% 128
2018
Q3
$4M Sell
25,250
-165
-0.6% -$25K 0.48% 61
2018
Q2
$3.56M Sell
25,415
-1,085
-4% -$149K 0.45% 67
2018
Q1
$3.52M Buy
26,500
+575
+2% +$78.5K 0.72% 43
2017
Q4
$3.23M Sell
25,925
-425
-2% -$52.5K 0.6% 50
2017
Q3
$3.27M Buy
26,350
+200
+0.8% +$23.7K 0.62% 49
2017
Q2
$2.98M Buy
26,150
+850
+3% +$91.4K 0.53% 62
2017
Q1
$2.66M Buy
+25,300
New +$2.54M 0.43% 70

Other funds holding FBT

Oxbow Advisors's FBT Position: Q3 2026 in Review

Oxbow Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 955 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #226.

Oxbow Advisors first reported a position in FBT in Q1 2017 and has held it in 33 quarters since. The position peaked at $4M in Q3 2018. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Oxbow Advisors held 955 shares of First Trust NYSE Arca Biotechnology Index Fund worth $260K as of Q3 2026.
  • Oxbow Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Oxbow Advisors's portfolio in Q3 2026, its #226 holding.
  • Oxbow Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and has held it in 33 quarters since.
  • Oxbow Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4M in Q3 2018.
  • 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Oxbow Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.